Catalog |
name |
Description |
price |
R-M1-9022 |
Bis-sulfone-PEG4-TCO |
Bis-sulfone-PEG4-TCO is utilized for the selective and specific labeling and modification of biomolecules such as proteins, peptides, or nucleic acids. The bis-sulfone functional groups provide sites for covalent attachment, while the PEG spacer enhances solubility and biocompatibility. Meanwhile, the TCO group permits subsequent bioorthogonal reactions with tetrazines, enabling specific and rapid labeling or modification of target molecules. |
price> |
R-M1-9023 |
Bromoacetamido-PEG3-TCO |
Bromoacetamido-PEG3-TCO is commonly utilized for the selective labeling and modification of biomolecules such as proteins, peptides, or nucleic acids. The bromoacetamido group provides a specific site for covalent attachment to thiol-containing biomolecules, while the PEG spacer enhances solubility and biocompatibility. The TCO group allows for subsequent bioorthogonal reactions with tetrazines, enabling specific and rapid labeling or modification of target molecules. |
price> |
R-M1-9024 |
Diazo-PEG3-TCO |
Diazo-PEG3-TCO is a type of small molecule compound that is composed of several functional groups. The diazo group is a functional group that contains two nitrogen atoms, which are highly reactive and can be used for a variety of chemical reactions.
The PEG3 group is a polyethylene glycol spacer, which is used to improve the solubility and stability of the compound in solution. The TCO group is a functional group that contains a strained cyclooctyne ring, which is highly reactive with other functional groups such as azides and alkynes. |
price> |
R-M1-9025 |
HyNic-PEG2-TCO |
HyNic-PEG2-TCO is often used for bioconjugation, specifically the selective labeling and modification of biomolecules such as proteins, peptides, and nucleic acids, in research and diagnostic applications. The HyNic group provides a specific site for covalent attachment to aldehyde or ketone-containing biomolecules, while the PEG spacer enhances solubility and biocompatibility. The TCO group enables subsequent bioorthogonal reactions with tetrazines, allowing for specific and rapid labeling or modification of target molecules. |
price> |
R-M1-9026 |
HyNic-PEG3-TCO |
HyNic-PEG3-TCO is frequently used for the selective labeling and modification of biomolecules such as proteins, peptides, or nucleic acids. The HyNic group provides a specific site for covalent attachment to aldehyde or ketone-containing biomolecules, while the PEG spacer enhances solubility and biocompatibility. The TCO group allows for subsequent bioorthogonal reactions with tetrazines, enabling specific and rapid labeling or modification of target molecules. |
price> |
R-M1-9036 |
D-acid-PEG4-Thalidomide-5-(PEG4-acid) |
D-acid-PEG4-Thalidomide-5-(PEG4-acid) is a chemical compound that consists of thalidomide, a drug with immunomodulatory and anti-inflammatory properties, coupled with polyethylene glycol (PEG) spacers. The PEG spacers help improve the solubility and pharmacokinetic properties of the compound. This type of modification is often used to enhance the efficacy and safety of drugs. The specific structure of this compound suggests that it is designed for targeted drug delivery or conjugation with other molecules for therapeutic purposes. |
price> |
R-M1-9037 |
Thalidomide-O-amido-PEG2-C2-NH2, HCl salt,cas2376990-30-4 |
Thalidomide-O-amido-PEG2-C2-NH2, HCl salt is a chemical compound consisting of thalidomide covalently linked to a PEG2-C2-NH2 group, and the addition of hydrochloride salt. Thalidomide is a medication with immunomodulatory and anti-inflammatory properties, while the PEG2-C2-NH2 group consists of polyethylene glycol and an amino group, which can help in improving the solubility and pharmacokinetic profile of the compound. |
price> |
R-M1-9038 |
Thalidomide-O-PEG8-Amine,HCl salt |
The chemical compound Thalidomide-O-PEG8-Amine, HCl salt consists of thalidomide covalently bonded to a PEG8 amine group, with the addition of hydrochloride salt. Thalidomide is a medication known for its immunomodulatory and anti-inflammatory properties. The PEG8 amine group, comprising an eight-unit polyethylene glycol chain and an amino group, is likely added to improve solubility and pharmacokinetic properties of the compound. The hydrochloride salt form is often used to enhance the compound stability and solubility. This compound is likely designed to enhance the pharmaceutical properties of thalidomide, making it more effective and suitable for therapeutic use. |
price> |
R-M1-9039 |
Thalidomide-PEG4-NH2, HCl salt,cas2387510-82-7 |
Thalidomide-PEG4-NH2,HCl salt is a chemical compound that is used for medicinal purposes. Thalidomide is a medication that is used to treat conditions such as leprosy and multiple myeloma, while PEG4-NH2 is a polyethylene glycol derivative that can modify the properties of drugs to improve their effectiveness. The addition of the HCl salt helps to stabilize the compound and make it suitable for use in pharmaceutical preparations. This compound is a salt form of thalidomide, which can improve its solubility and bioavailability, making it easier for the body to absorb and utilize. |
price> |
R-M1-9040 |
Thalidomide-O-PEG2-Amine TFA salt,CASCAS: 1957236-10-0 |
Thalidomide-O-PEG2-Amine TFA salt is a chemical compound used for medicinal purposes. Thalidomide is a medication that is primarily used to treat conditions such as leprosy and multiple myeloma. The addition of O-PEG2-Amine, a polyethylene glycol derivative, can modify the properties of drugs to improve their effectiveness. The TFA salt form is used to stabilize the compound and make it suitable for use in pharmaceutical preparations. This salt form of thalidomide can also enhance its solubility and bioavailability, facilitating easier absorption and utilization by the body. |
price> |